Altered Expression of Three EGFR Posttranslational Regulators MDGI, MIG6, and EIG121 in Invasive Breast Carcinomas
Epidermal growth factor receptor (EGFR) signalling is a highly regulated process with a tight balance between receptor activation and inactivation in invasive breast carcinomas (IBCs) particularly in triple-negative carcinomas (TNC). Clinical trials using anti-EGFR therapies are actually performed a...
Saved in:
| Main Authors: | Didier Meseure, Kinan Drak Alsibai, Sophie Vacher, Rana Hatem, Andre Nicolas, Celine Callens, Florence Lerebours, Ivan Bieche |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Analytical Cellular Pathology |
| Online Access: | http://dx.doi.org/10.1155/2020/9268236 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
eIg-based bispecific T-cell engagers targeting EGFR: Format matters
by: Lennart Kühl, et al.
Published: (2023-12-01) -
Travaux de diplôme à I’EIG: formation et recherche
by: Jacques Painot
Published: (1999-05-01) -
Diverse perspectives on proteomic posttranslational modifications to address EGFR-TKI resistance in non-small cell lung cancer
by: Yuhong Ma, et al.
Published: (2024-12-01) -
Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis
by: Agata N. Burska, et al.
Published: (2014-01-01) -
Landscape of Histone Posttranslational Modifications in Osteoarthritis
by: Zhao S, et al.
Published: (2025-06-01)